Comparison of the CINP Guidelines to Other Previously Developed Guidelines for Maintenance Phase
| . | CINP 2017 . | WFSBP 2013a . | CANMAT and ISBD 2013 . | NICE 2014 b . | BAP 2016b . |
|---|---|---|---|---|---|
| Aripiprazole | 1 | 1 | 1 | - | 3 |
| Lithium | 1 | 1 | 1 | 1 | 1 |
| Olanzapine | 1 | 2 | 1 | 1 | 2 |
| Paliperidone | 1 | 3 | 2 | - | 3 |
| Quetiapine | 1 | 1 | 1 | 1 | 2 |
| Risperidone | 1 | 2 | - | - | 3 |
| RLAI | 1 | - | 1 | - | 2 |
| OFC | 2 | - | 2 | - | - |
| Carbamazepine | 2 | 4 | 2 | - | 2 |
| Valproate | 2 | 3 | 1 | 1 | 2 |
| Lamotrigine | 3 | 1 | 1 | - | 2 |
| Haloperidol | 4 | - | - | - | 3 |
| Venlafaxine | 4 | - | - | - | - |
| ECT | 5 | 4 | 3 | - | - |
| Ziprasidone | 5 | 3 | - | - | 3 |
| Continue most recent episode treatment | NR | - | - | 1 | - |
| Antidepressants | - | 3 | NR | - | 4 |
| Asenapine | - | 4 | 3 | - | 3 |
| Gabapentin | - | 4 | NR | NR | - |
| Topiramate | - | 4 | NR | - | - |
| . | CINP 2017 . | WFSBP 2013a . | CANMAT and ISBD 2013 . | NICE 2014 b . | BAP 2016b . |
|---|---|---|---|---|---|
| Aripiprazole | 1 | 1 | 1 | - | 3 |
| Lithium | 1 | 1 | 1 | 1 | 1 |
| Olanzapine | 1 | 2 | 1 | 1 | 2 |
| Paliperidone | 1 | 3 | 2 | - | 3 |
| Quetiapine | 1 | 1 | 1 | 1 | 2 |
| Risperidone | 1 | 2 | - | - | 3 |
| RLAI | 1 | - | 1 | - | 2 |
| OFC | 2 | - | 2 | - | - |
| Carbamazepine | 2 | 4 | 2 | - | 2 |
| Valproate | 2 | 3 | 1 | 1 | 2 |
| Lamotrigine | 3 | 1 | 1 | - | 2 |
| Haloperidol | 4 | - | - | - | 3 |
| Venlafaxine | 4 | - | - | - | - |
| ECT | 5 | 4 | 3 | - | - |
| Ziprasidone | 5 | 3 | - | - | 3 |
| Continue most recent episode treatment | NR | - | - | 1 | - |
| Antidepressants | - | 3 | NR | - | 4 |
| Asenapine | - | 4 | 3 | - | 3 |
| Gabapentin | - | 4 | NR | NR | - |
| Topiramate | - | 4 | NR | - | - |
Abbreviations: ECT, electroconvulsive therapy; NR, not recommended; OFC, olanzapine-fluoxetine combination;
RLAI, risperidone long-acting injectable.
The grading is not uniform; instead it reflects the grading utilized by individual guidelines and the table aims only to give an image of how different guidelines prioritize treatment options.
a WFSBP: Recommendation grades and subsequent positioning could be either based on efficacy in the prevention of mania, depression or any episode. Thus, numbers do not reflect the sequence of treatment in an individual patient.
b NICE and BAP ordering is on the basis of line of treatment.
Comparison of the CINP Guidelines to Other Previously Developed Guidelines for Maintenance Phase
| . | CINP 2017 . | WFSBP 2013a . | CANMAT and ISBD 2013 . | NICE 2014 b . | BAP 2016b . |
|---|---|---|---|---|---|
| Aripiprazole | 1 | 1 | 1 | - | 3 |
| Lithium | 1 | 1 | 1 | 1 | 1 |
| Olanzapine | 1 | 2 | 1 | 1 | 2 |
| Paliperidone | 1 | 3 | 2 | - | 3 |
| Quetiapine | 1 | 1 | 1 | 1 | 2 |
| Risperidone | 1 | 2 | - | - | 3 |
| RLAI | 1 | - | 1 | - | 2 |
| OFC | 2 | - | 2 | - | - |
| Carbamazepine | 2 | 4 | 2 | - | 2 |
| Valproate | 2 | 3 | 1 | 1 | 2 |
| Lamotrigine | 3 | 1 | 1 | - | 2 |
| Haloperidol | 4 | - | - | - | 3 |
| Venlafaxine | 4 | - | - | - | - |
| ECT | 5 | 4 | 3 | - | - |
| Ziprasidone | 5 | 3 | - | - | 3 |
| Continue most recent episode treatment | NR | - | - | 1 | - |
| Antidepressants | - | 3 | NR | - | 4 |
| Asenapine | - | 4 | 3 | - | 3 |
| Gabapentin | - | 4 | NR | NR | - |
| Topiramate | - | 4 | NR | - | - |
| . | CINP 2017 . | WFSBP 2013a . | CANMAT and ISBD 2013 . | NICE 2014 b . | BAP 2016b . |
|---|---|---|---|---|---|
| Aripiprazole | 1 | 1 | 1 | - | 3 |
| Lithium | 1 | 1 | 1 | 1 | 1 |
| Olanzapine | 1 | 2 | 1 | 1 | 2 |
| Paliperidone | 1 | 3 | 2 | - | 3 |
| Quetiapine | 1 | 1 | 1 | 1 | 2 |
| Risperidone | 1 | 2 | - | - | 3 |
| RLAI | 1 | - | 1 | - | 2 |
| OFC | 2 | - | 2 | - | - |
| Carbamazepine | 2 | 4 | 2 | - | 2 |
| Valproate | 2 | 3 | 1 | 1 | 2 |
| Lamotrigine | 3 | 1 | 1 | - | 2 |
| Haloperidol | 4 | - | - | - | 3 |
| Venlafaxine | 4 | - | - | - | - |
| ECT | 5 | 4 | 3 | - | - |
| Ziprasidone | 5 | 3 | - | - | 3 |
| Continue most recent episode treatment | NR | - | - | 1 | - |
| Antidepressants | - | 3 | NR | - | 4 |
| Asenapine | - | 4 | 3 | - | 3 |
| Gabapentin | - | 4 | NR | NR | - |
| Topiramate | - | 4 | NR | - | - |
Abbreviations: ECT, electroconvulsive therapy; NR, not recommended; OFC, olanzapine-fluoxetine combination;
RLAI, risperidone long-acting injectable.
The grading is not uniform; instead it reflects the grading utilized by individual guidelines and the table aims only to give an image of how different guidelines prioritize treatment options.
a WFSBP: Recommendation grades and subsequent positioning could be either based on efficacy in the prevention of mania, depression or any episode. Thus, numbers do not reflect the sequence of treatment in an individual patient.
b NICE and BAP ordering is on the basis of line of treatment.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
